Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia

Publication date: Available online 15 April 2020Source: CytotherapyAuthor(s): Rajeswaran Mani, Girish Rajgolikar, Jessica Nunes, Kevan Zapolnik, Ronni Wasmuth, Xiaokui Mo, John C. Byrd, Dean A. Lee, Natarajan Muthusamy, Sumithira Vasu
Source: Cytotherapy - Category: Cytology Source Type: research